|
|
||||||||
Editorials |
Division of Nephrology, Hennepin County Medical Center, 701 Park Ave., Minneapolis, MN 55415, Fax 612-347-2003
The glomerular filtration rate (GFR) is generally considered the best measure of renal function despite the fact that the kidney performs an array of duties, including salt and water balance, erythropoiesis, bone metabolism, electrolyte homeostasis, and blood pressure control. GFR is traditionally measured as the renal clearance of a particular substance from plasma and is expressed as the volume of plasma that can be completely cleared of that substance in a unit of time. The ideal marker for GFR determinations would appear endogenously in the plasma at a constant rate, be freely filtered at the glomerulus, be neither reabsorbed nor secreted by the renal tubule, and undergo no extrarenal elimination. Although the ideal marker for measuring GFR has yet to be found, these characteristics can be useful benchmarks for comparing the advantages and disadvantages of new methods for GFR quantification.
Measurement of urea marked the beginning of efforts to quantify renal function with its isolation by Rouelle in 1773 (1). Subsequently, Strauss introduced blood urea as a diagnostic test for renal disease in 1903. The concept of clearance as a measure of renal function followed in 1929 (2) and was subsequently extended to creatinine in the early 1930s (1).
Blood urea nitrogen (BUN) concentration is generally recognized
References
The following articles in journals at HighWire Press have cited this article:
![]() |
P.-A. Poletti, P. Saudan, A. Platon, B. Mermillod, A.-M. Sautter, B. Vermeulen, F. P. Sarasin, C. D. Becker, and P.-Y. Martin IV N-Acetylcysteine and Emergency CT: Use of Serum Creatinine and Cystatin C as Markers of Radiocontrast Nephrotoxicity Am. J. Roentgenol., September 1, 2007; 189(3): 687 - 692. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Koenig, D. Twardella, H. Brenner, and D. Rothenbacher Plasma Concentrations of Cystatin C in Patients with Coronary Heart Disease and Risk for Secondary Cardiovascular Events: More than Simply a Marker of Glomerular Filtration Rate Clin. Chem., February 1, 2005; 51(2): 321 - 327. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Hoffmann, M. Fischereder, B. Kruger, W. Drobnik, and B. K. Kramer The Value of N-Acetylcysteine in the Prevention of Radiocontrast Agent-Induced Nephropathy Seems Questionable J. Am. Soc. Nephrol., February 1, 2004; 15(2): 407 - 410. [Abstract] [Full Text] [PDF] |
||||
![]() |
G.D. Tan, A.V. Lewis, T.J. James, P. Altmann, R.P. Taylor, and J.C. Levy Clinical Usefulness of Cystatin C for the Estimation of Glomerular Filtration Rate in Type 1 Diabetes: Reproducibility and accuracy compared with standard measures and iohexol clearance Diabetes Care, November 1, 2002; 25(11): 2004 - 2009. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. F. Laterza, C. P. Price, and M. G. Scott Cystatin C: An Improved Estimator of Glomerular Filtration Rate? Clin. Chem., May 1, 2002; 48(5): 699 - 707. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Risch, R. Herklotz, A. Blumberg, and A. R. Huber Effects of Glucocorticoid Immunosuppression on Serum Cystatin C Concentrations in Renal Transplant Patients Clin. Chem., November 1, 2001; 47(11): 2055 - 2059. [Full Text] [PDF] |
||||
![]() |
K. Itoh Determination of Glomerular Filtration Rate by Means of Newly Developed Plastic Scintillation Counter Both With and Without Dilution Procedures J. Nucl. Med., October 1, 2001; 42(10): 1484 - 1488. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Stowe, D. Lawrence, D. J. Newman, and E. J. Lamb Analytical Performance of a Particle-enhanced Nephelometric Immunoassay for Serum Cystatin C Using Rate Analysis Clin. Chem., August 1, 2001; 47(8): 1482 - 1485. [Full Text] [PDF] |
||||
![]() |
J. B Ubbink Metabolic markers of vitamin nutritional status Am. J. Clinical Nutrition, November 1, 1999; 70(5): 789 - 790. [Full Text] |
||||
![]() |
F. Priem, H. Althaus, M. Birnbaum, P. Sinha, H. S. Conradt, and K. Jung ß-Trace Protein in Serum: A New Marker of Glomerular Filtration Rate in the Creatinine-Blind Range Clin. Chem., April 1, 1999; 45(4): 567 - 568. [Full Text] [PDF] |
||||
![]() |
D. Stickle, B. Cole, K. Hock, K. A. Hruska, and M. G. Scott Correlation of plasma concentrations of cystatin C and creatinine to inulin clearance in a pediatric population Clin. Chem., June 1, 1998; 44(6): 1334 - 1338. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |